⌘K
Loading ticker…
As of 2026-08-24, Amarin Corp Plc (AMRN) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.8%, relative volume 2.11×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AMRN is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -6.0% / -6.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
AMRN is held by 2 ETFs as of Mar 2026. Top owner: SPDW at 0.00% weight, $241K notional.
Held by 2 ETFs · $354K across latest filings · largest weight 0.01% (GWX).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SPDWState Street SPDR Portfolio Developed World ex-US ETF | 0.00% | $241K | — |
| GWX | 0.01% | $113K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AMRN Jan avg: 27.34% median: 24.37% win: 100% σ: 19.93% n: 4 2022-04-12 → 2026-07-31 | AMRN Feb avg: -2.42% median: -5.65% win: 25% σ: 7.76% n: 4 2022-04-12 → 2026-07-31 | AMRN Mar avg: -13.85% median: -17.03% win: 25% σ: 13.14% n: 4 2022-04-12 → 2026-07-31 | AMRN Apr avg: -1.98% median: -3.67% win: 40% σ: 14.96% n: 5 2022-04-12 → 2026-07-31 | AMRN May avg: -10.75% median: -6.07% win: 40% σ: 21.43% n: 5 2022-04-12 → 2026-07-31 | AMRN Jun avg: 6.79% median: 2.76% win: 80% σ: 21.76% n: 5 2022-04-12 → 2026-07-31 | AMRN Jul avg: -6.36% median: -10.48% win: 20% σ: 5.82% n: 5 2022-04-12 → 2026-07-31 | AMRN Aug avg: -7.12% median: -9.78% win: 25% σ: 7.35% n: 4 2022-04-12 → 2026-07-31 (current) | AMRN Sep avg: -2.72% median: -3.70% win: 50% σ: 9.33% n: 4 2022-04-12 → 2026-07-31 | AMRN Oct avg: -4.89% median: -4.04% win: 25% σ: 15.48% n: 4 2022-04-12 → 2026-07-31 | AMRN Nov avg: -2.18% median: -4.23% win: 25% σ: 10.62% n: 4 2022-04-12 → 2026-07-31 | AMRN Dec avg: -0.11% median: 0.47% win: 50% σ: 10.51% n: 4 2022-04-12 → 2026-07-31 |